ArticleCancer reports (Hoboken, N.J.)2025

TGFβ1 and SMAD3 Expression Are Associated With Survival After the Immune Checkpoint Inhibitor Therapy for Small Cell Lung Cancer.

Zenta Seto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.